Stay updated with breaking news from Ben Larman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A prospective study by Johns Hopkins Medicine researchers demonstrates that convalescent plasma (shown here) – a blood product collected from patients
Published: Apr 05, 2021 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- ImmuneID, Inc., a precision immunology company employing a proprietary platform to identify and therapeutically target antibody interactions that drive immune diseases, today announced that Annalisa D’Andrea, Ph.D., has been appointed President and Chief Scientific Officer. Dr. D’Andrea brings more than 25 years of experience in translational research in immunology to ImmuneID. “The addition of Annalisa as President and CSO is an important milestone for ImmuneID, as the company applies its platform to identify promisi...
Story Tips from Johns Hopkins Experts on Covid-19